Technical Analysis for SGIOF - Shionogi & Co Ltd

Grade Last Price % Change Price Change
grade C 54.17 2.02% 1.0700
SGIOF closed up 2.02 percent on Monday, August 19, 2019, on 51 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical SGIOF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 2.02%
Stochastic Reached Oversold Weakness 2.02%
Gapped Up Strength 2.02%
Below Lower BB Weakness 2.02%
Oversold Stochastic Weakness 2.02%
Fell Below 200 DMA Bearish 2.03%
MACD Bearish Signal Line Cross Bearish 2.03%

Older signals for SGIOF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company primarily focuses on metabolic syndrome, pain, infectious diseases, cholesterol medication, anti-hypertension drugs, depression treatment, prescription drugs, OTC drugs, and diagnostics. Its primary products include Cymbalta, a serotonin and noradrenaline reuptake inhibitor used for the treatment of depression, anxiety, diabetic neuropathic pain, fibromyalgia pain, chronic lower back pain, and osteoarthritis pain; Intuniv, a selective a2 adrenergic receptor agonist to treat attention-deficit hyperactivity disorder; Xofluza, an anti-influenza agent; and Symproic, a cancer pain analgesic tablet. It has a research collaborative agreement with National University Corporation Kyoto University to focus on drug discovery and medical research for the treatment of psychiatric disorders; strategic collaboration with Sage Therapeutics, Inc. to develop and commercialize SAGE-217 for MDD and other indications; license and research collaboration for the treatment of mycobacterial diseases with Hsiri Therapeutics Inc.; a strategic collaboration with Tetra Discovery Partners LLC for the clinical development and commercialization of BPN14770, a selective phosphodiesterase-4D allosteric inhibitor; and a collaborative research agreement with PeptiDream Inc. for the discovery and development of a series of blood brain barrier penetrating peptide drug-conjugates. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.
Chemistry RTT Cancer Pharmaceuticals Drugs Pain Infectious Diseases Chemical Compounds Drug Discovery Osteoarthritis Depression Fibromyalgia Psychiatric Disorders Back Pain Metabolic Syndrome Treatment Of Depression Attention Deficit Hyperactivity Disorder Kyoto University Depression Treatment Duloxetine Mycobacterial Diseases Naldemedine National University Corporation Kyoto University Shionogi Symproic Treatment Of Mycobacterial Diseases Treatment Of Psychiatric Disorders
Is SGIOF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 75.0
52 Week Low 0.5
Average Volume 592
200-Day Moving Average 56.4485
50-Day Moving Average 58.5022
20-Day Moving Average 56.6545
10-Day Moving Average 56.293
Average True Range 0.9628
ADX 12.44
+DI 36.0245
-DI 58.7095
Chandelier Exit (Long, 3 ATRs ) 56.2815
Chandelier Exit (Short, 3 ATRs ) 55.7784
Upper Bollinger Band 59.8355
Lower Bollinger Band 53.4735
Percent B (%b) 0.11
BandWidth 11.22947
MACD Line -1.1217
MACD Signal Line -0.8053
MACD Histogram -0.3164
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 54.1700
Resistance 3 (R3) 54.1700 54.1700 54.1700
Resistance 2 (R2) 54.1700 54.1700 54.1700 54.1700
Resistance 1 (R1) 54.1700 54.1700 54.1700 54.1700 54.1700
Pivot Point 54.1700 54.1700 54.1700 54.1700 54.1700
Support 1 (S1) 54.1700 54.1700 54.1700 54.1700 54.1700
Support 2 (S2) 54.1700 54.1700 54.1700 54.1700
Support 3 (S3) 54.1700 54.1700 54.1700
Support 4 (S4) 54.1700